Polymeric carriers for regional drug therapy

A J Domb1

  • 1Department of Pharmaceutical Chemistry, School of Pharmacy, Faculty of Medicine, Hebrew University of Jerusalem, Israel. ADOMB@md2.huji.ac.il

Insights

Localized drug delivery using degradable polymer systems offers a promising alternative to conventional therapies. This approach enhances drug concentration at the disease site, minimizing systemic exposure and improving treatment efficacy for localized conditions.

Area of Science:

  • Biomedical Engineering
  • Materials Science
  • Pharmacology

Background:

  • Conventional drug therapies face limitations in treating localized diseases like solid tumors and infections.
  • Inadequate drug supply to diseased tissues contributes to high recurrence rates and treatment failure.
  • There is a need for advanced drug delivery systems to improve therapeutic outcomes.

Purpose of the Study:

  • To explore the potential of degradable polymeric delivery systems for localized drug administration.
  • To enhance drug specificity and efficacy at the target site.
  • To reduce systemic drug distribution and associated side effects.

Main Methods:

  • Development and implantation of biodegradable polymer-based drug depots at the disease site.
  • In situ release of therapeutic agents from the degrading polymer matrix.
  • Monitoring of local drug concentration and systemic drug levels.

Main Results:

  • Polymeric delivery systems enable sustained high local drug concentrations.
  • Systemic drug distribution is significantly minimized compared to conventional methods.
  • Degradable polymers facilitate controlled drug release and subsequent elimination from the body.

Conclusions:

  • Local administration of drugs via degradable polymeric systems is a viable strategy for treating localized diseases.
  • This approach offers improved therapeutic potential by maximizing drug efficacy at the target site.
  • Biodegradable polymers represent a promising platform for advanced drug delivery applications.

Related Concept Videos

Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Modified-Release Drug Delivery Systems: Rate-Programmed II01:19

Modified-Release Drug Delivery Systems: Rate-Programmed II

Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Drug Delivery Systems: Different Types01:27

Drug Delivery Systems: Different Types

Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
Modified-Release Drug Delivery Systems: Classification01:23

Modified-Release Drug Delivery Systems: Classification

Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...